{"version":"1.0","type":"link","title":"Structure-Based Discovery of HS34: A Highly Selective and Orally Bioavailable CDK9 Inhibitor for Triple-Negative Breast Cancer.","author_name":"Huang Y 외","author_url":"https://prs-insight.online/author/Huang%20Y","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/79795","thumbnail_width":1200,"thumbnail_height":630}